[ORGANIZATION]
pancreatic ductal adenocarcinoma
Featured in 1 tracked story · first seen
Situations
FDA approves Rasonque for pancreatic cancer; lung cancer use
36 clusters · 292 sources · last updated
Latest: Daraxonrasib shows clinical promise for RAS-mutant lung cancer
On 26 August 2026, the U.S. Food and Drug Administration (FDA) granted expedited approval to daraxonrasib, marketed as Rasonque, for treating adults with metastatic pancreatic ductal adenocarcinoma (PDAC). Developed by R